New Study Released on Fotona's NightLase® Anti-Snoring Laser Treatment
29 July 2022
Fotona's NightLase® anti-snoring laser treatment has been gaining worldwide recognition for it's safety and efficacy.
A newly published article by Dr. Valerie A. Picavet, et al. in the prestigious European Archives of Oto-Rhino-Laryngology presents the data from a recent study that assessed the safety and efficacy of the minimally invasive NightLase® therapy, comparing the results with a sham treatment.
The authors of the study concluded that:
Taking into account the minimal invasiveness of NightLase, this procedure seems to represent a valuable, low-risk treatment option for primary snoring/mild OSAS."
It should also be noted that the treatment was well tolerated by patients, with no local anaesthesia required.
The full text of the journal article, titled: Treatment of snoring using a non‑invasive Er:YAG laser with SMOOTH mode (NightLase): a randomized controlled trial, can be viewed on the publisher's website.
